Matthew L Sherman - Net Worth and Insider Trading
Matthew L Sherman Net Worth
The estimated net worth of Matthew L Sherman is at least $15 Million dollars as of 2024-04-28. Matthew L Sherman is the EVP & Chief Medical Officer of Acceleron Pharma Inc and owns about 77,267 shares of Acceleron Pharma Inc (XLRN) stock worth over $14 Million. Matthew L Sherman is also the EVP & Chief Medical Officer of Deciphera Pharmaceuticals Inc and owns about 94,079 shares of Deciphera Pharmaceuticals Inc (DCPH) stock worth over $1 Million. Details can be seen in Matthew L Sherman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Matthew L Sherman has not made any transactions after 2024-01-16 and currently still holds the listed stock(s).
Transaction Summary of Matthew L Sherman
Matthew L Sherman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Matthew L Sherman owns 5 companies in total, including Deciphera Pharmaceuticals Inc (DCPH) , Pieris Pharmaceuticals Inc (PIRS) , and Lumos Pharma Inc (LUMO) among others .
Click here to see the complete history of Matthew L Sherman’s form 4 insider trades.
Insider Ownership Summary of Matthew L Sherman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| DCPH | Deciphera Pharmaceuticals Inc | 2024-01-16 | EVP & Chief Medical Officer |
| PIRS | Pieris Pharmaceuticals Inc | 2023-06-21 | director |
| LUMO | Lumos Pharma Inc | 2018-04-27 | director |
| PULM | Pulmatrix Inc | 2016-09-29 | director |
| XLRN | Acceleron Pharma Inc | 2018-04-03 | EVP & Chief Medical Officer |
Matthew L Sherman Latest Holdings Summary
Matthew L Sherman currently owns a total of 2 stocks. Among these stocks, Matthew L Sherman owns 77,267 shares of Acceleron Pharma Inc (XLRN) as of April 3, 2018, with a value of $14 Million and a weighting of 90.93%. Matthew L Sherman also owns 94,079 shares of Deciphera Pharmaceuticals Inc (DCPH) as of January 16, 2024, with a value of $1 Million and a weighting of 9.07%.
Latest Holdings of Matthew L Sherman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| XLRN | Acceleron Pharma Inc | 2018-04-03 | 77,267 | 178.75 | 13,811,476 |
| DCPH | Deciphera Pharmaceuticals Inc | 2024-01-16 | 94,079 | 14.65 | 1,378,257 |
Holding Weightings of Matthew L Sherman
Matthew L Sherman Form 4 Trading Tracker
According to the SEC Form 4 filings, Matthew L Sherman has made a total of 0 transactions in Acceleron Pharma Inc (XLRN) over the past 5 years. The most-recent trade in Acceleron Pharma Inc is the sale of 4,600 shares on April 3, 2018, which brought Matthew L Sherman around $176,778.
According to the SEC Form 4 filings, Matthew L Sherman has made a total of 11 transactions in Deciphera Pharmaceuticals Inc (DCPH) over the past 5 years, including 0 buys and 11 sells. The most-recent trade in Deciphera Pharmaceuticals Inc is the sale of 2,435 shares on January 16, 2024, which brought Matthew L Sherman around $35,234.
Insider Trading History of Matthew L Sherman
- 1
Matthew L Sherman Trading Performance
Matthew L Sherman Ownership Network
Ownership Network List of Matthew L Sherman
Ownership Network Relation of Matthew L Sherman
Matthew L Sherman Owned Company Details
What does Deciphera Pharmaceuticals Inc do?
Who are the key executives at Deciphera Pharmaceuticals Inc?
Matthew L Sherman is the EVP & Chief Medical Officer of Deciphera Pharmaceuticals Inc. Other key executives at Deciphera Pharmaceuticals Inc include Chief Financial Officer Thomas Patrick Kelly , Chief Commercial Officer Daniel C. Martin , and SVP & Regulatory & Quality Jama Pitman .
Deciphera Pharmaceuticals Inc (DCPH) Insider Trades Summary
Over the past 18 months, Matthew L Sherman made 6 insider transaction in Deciphera Pharmaceuticals Inc (DCPH) with a net sale of 14,587. Other recent insider transactions involving Deciphera Pharmaceuticals Inc (DCPH) include a net sale of 26,559 shares made by Daniel C. Martin , a net sale of 11,601 shares made by Thomas Patrick Kelly , and a net sale of 7,534 shares made by Jama Pitman .
In summary, during the past 3 months, insiders sold 0 shares of Deciphera Pharmaceuticals Inc (DCPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 154,121 shares of Deciphera Pharmaceuticals Inc (DCPH) were sold and 1,687,666 shares were bought by its insiders, resulting in a net purchase of 1,533,545 shares.
Deciphera Pharmaceuticals Inc (DCPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Deciphera Pharmaceuticals Inc Insider Transactions
Matthew L Sherman Mailing Address
Above is the net worth, insider trading, and ownership report for Matthew L Sherman. You might contact Matthew L Sherman via mailing address: C/o Deciphera Pharmaceuticals, Inc., 200 Smith Street, Waltham Ma 02451.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
